Skip to main content
SpringerLink
Log in

Liver Fibrosis and Its Assessment

  • Chapter
  • First Online:
Operative Techniques in Liver Resection

  • 2127 Accesses

Abstract

Liver fibrosis is a reversible reaction of liver wound repair that is characterized as the accumulation of an extracellular matrix (i.e., the formation of scar tissue). Liver fibrosis occurs after chronic, non-self-limiting liver disease. It is essential to assess the existence or the severity of liver fibrosis in patients who need or have had partial liver resection. It not only can determine whether the patient can tolerate the operation, but it is also related to the postoperative safety of the patient. There are a variety of methods for diagnosing liver fibrosis, including invasive and noninvasive methods. The purpose of this chapter is to introduce the methods to diagnose liver fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–56.

    Article  PubMed  CAS  Google Scholar 

  2. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–18.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology (Baltimore, Md). 2003;37:493–503.

    Article  CAS  Google Scholar 

  4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer J Int du Cancer. 2010;127:2893–917.

    Article  CAS  Google Scholar 

  5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  6. Adler B, Ashkar S, Cantor H, Weber GF. Costimulation by extracellular matrix proteins determines the response to TCR ligation. Cell Immunol. 2001;210:30–40.

    Article  PubMed  CAS  Google Scholar 

  7. Schrader J, Gordon-Walker TT, Aucott RL, van Deemter M, Quaas A, Walsh S, et al. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology (Baltimore, Md). 2011;53:1192–205.

    Article  CAS  Google Scholar 

  8. Yang C, Zeisberg M, Lively JC, Nyberg P, Afdhal N, Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res. 2003;63:8312–7.

    PubMed  CAS  Google Scholar 

  9. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–9.

    Article  PubMed  CAS  Google Scholar 

  10. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology (Baltimore, Md). 1994;20:15–20.

    Google Scholar 

  11. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13:372–4.

    Article  PubMed  CAS  Google Scholar 

  12. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409–17.

    Article  PubMed  CAS  Google Scholar 

  13. Wu J, Danielsson A. Detection of hepatic fibrogenesis: a review of available techniques. Scand J Gastroenterol. 1995;30:817–25.

    Article  PubMed  CAS  Google Scholar 

  14. Masuhara M, Yasunaga M, Tanigawa K, Tamura F, Yamashita S, Sakaida I, et al. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology (Baltimore, Md). 1996;24:323–9.

    CAS  Google Scholar 

  15. Schiavon LL, Narciso-Schiavon JL, CarvalhoFilho RJ, Sampaio JP, Medina-Pestana JO, Lanzoni VP, et al. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection. J Viral Hepat. 2008;15:666–74.

    Article  PubMed  CAS  Google Scholar 

  16. Lebensztejn DM, Kaczmarski M, Sobaniec-Lotowska M, Bauer M, Voelker M, Schuppan D. Serum laminin-2 and hyaluronan predict severe liver fibrosis in children with chronic hepatitis B. Hepatology (Baltimore, Md). 2004;39:868–9.

    Article  Google Scholar 

  17. Mak KM, Chen LL, Lee TF. Codistribution of collagen type IV and laminin in liver fibrosis of elderly cadavers: immunohistochemical marker of perisinusoidal basement membrane formation. Anat Rec (Hoboken, NJ: 2007). 2013;296:953–64.

    Article  CAS  Google Scholar 

  18. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem. 1996;42:558–63.

    PubMed  CAS  Google Scholar 

  19. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis. Hepatology (Baltimore, Md). 2014;61(1):292–302.

    Article  Google Scholar 

  20. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology. 1988;95:734–9.

    PubMed  CAS  Google Scholar 

  21. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat. 1997;4:199–208.

    Article  PubMed  CAS  Google Scholar 

  22. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92:1302–4.

    PubMed  CAS  Google Scholar 

  23. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001;357:1069–75.

    Article  PubMed  CAS  Google Scholar 

  24. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol. 2001;96:3142–6.

    Article  PubMed  CAS  Google Scholar 

  25. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology (Baltimore, Md). 2002;36:986–92.

    Article  Google Scholar 

  26. Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, et al. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C. Hepatogastroenterology. 2002;49:478–81.

    PubMed  Google Scholar 

  27. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (Baltimore, Md). 2003;38:518–26.

    Article  Google Scholar 

  28. Patel K, Gordon SC, Jacobson I, Hezode C, Oh E, Smith KM, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol. 2004;41:935–42.

    Article  PubMed  CAS  Google Scholar 

  29. Leroy V, Monier F, Bottari S, Trocme C, Sturm N, Hilleret MN, et al. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol. 2004;99:271–9.

    Article  PubMed  CAS  Google Scholar 

  30. Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology (Baltimore, Md). 2005;42:1373–81.

    Article  Google Scholar 

  31. Islam S, Antonsson L, Westin J, Lagging M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol. 2005;40:867–72.

    Article  PubMed  Google Scholar 

  32. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51:1867–73.

    Article  PubMed  CAS  Google Scholar 

  33. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology (Baltimore, Md). 2005;42:282–92.

    Article  Google Scholar 

  34. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology (Baltimore, Md). 2005;42:1437–45.

    Article  Google Scholar 

  35. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology (Baltimore, Md). 2006;43:1317–25.

    Article  CAS  Google Scholar 

  36. Ohta T, Sakaguchi K, Fujiwara A, Fujioka S, Iwasaki Y, Makino Y, et al. Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. Actamedica Okayama. 2006;60:77–84.

    Google Scholar 

  37. Obrador BD, Prades MG, Gomez MV, Domingo JP, Cueto RB, Rue M, et al. A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory, and ultrasound findings. Eur J Gastroenterol Hepatol. 2006;18:57–62.

    Article  PubMed  Google Scholar 

  38. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology (Baltimore, Md). 2007;45:297–306.

    Article  Google Scholar 

  39. Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology (Baltimore, Md). 2008;47:789–98.

    Article  CAS  Google Scholar 

  40. Hsieh YY, Tung SY, Lee IL, Lee K, Shen CH, Wei KL, et al. FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med J. 2009;32:614–22.

    PubMed  Google Scholar 

  41. Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. King’s Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009;21:730–8.

    Article  PubMed  Google Scholar 

  42. Omran MM, Farid K, Emran TM, Attallah AA. Fibro-alpha score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients. Arab J Gastroenterol: Off Publ Pan-Arab Assoc Gastroenterol. 2011;12:74–9.

    Article  Google Scholar 

  43. Ahmad W, Ijaz B, Javed FT, Gull S, Kausar H, Sarwar MT, et al. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol. 2011;11:44.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Cheung KJ, Tilleman K, Deforce D, Colle I, Moreno C, Gustot T, et al. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2011;23:701–10.

    Article  PubMed  CAS  Google Scholar 

  45. Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Lee YJ, et al. Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C. Dig Dis Sci. 2011;56:555–63.

    Article  PubMed  CAS  Google Scholar 

  46. Attallah AM, Omran MM, Farid K, El-Bendary M, Emran TM, Albannan MS, et al. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients. Clinicachimicaacta; Int J Clin Chem. 2012;413:1725–30.

    Article  CAS  Google Scholar 

  47. Attallah AM, Abdallah SO, Attallah AA, Omran MM, Farid K, Nasif WA, et al. Diagnostic value of fibronectin discriminant score for predicting liver fibrosis stages in chronic hepatitis C virus patients. Ann Hepatol. 2013;12:44–53.

    PubMed  Google Scholar 

  48. Bolondi L, Li Bassi S, Gaiani S, Zironi G, Benzi G, Santi V, et al. Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology. 1991;178:513–6.

    Article  PubMed  CAS  Google Scholar 

  49. Vilgrain V. Ultrasound of diffuse liver disease and portal hypertension. Eur Radiol. 2001;11:1563–77.

    Article  PubMed  CAS  Google Scholar 

  50. Kaneko T, Teshigawara O, Sugimoto H, Hirota M, Inoue S, Takeda S, et al. Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver. Liver Int: Off J Int Assoc Study Liver. 2005;25:288–93.

    Article  Google Scholar 

  51. Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut. 2005;54:128–33.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  52. Xu HX, Lu MD, Zhou YQ, Zhang QP, Yin XY, Xie XY, et al. Three-dimensional gray scale volume rendering of the liver: preliminary clinical experience. J Ultrasound Med:Off J Am Inst Ultrasound Med. 2002;21:961–70.

    Google Scholar 

  53. Kanamoto M, Shimada M, Ikegami T, Uchiyama H, Imura S, Morine Y, et al. Real time elastography for noninvasive diagnosis of liver fibrosis. J Hepatobiliary Pancreat Surg. 2009;16:463–7.

    Article  PubMed  Google Scholar 

  54. Chon YE, Choi EH, Song KJ, Park JY, Kim do Y, Han KH, et al. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One. 2012;7, e44930.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  55. Friedrich-Rust M, Nierhoff J, Lupsor M, Sporea I, Fierbinteanu-Braticevici C, Strobel D, et al. Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat. 2012;19:e212–9.

    Article  PubMed  CAS  Google Scholar 

  56. Romero-Gomez M, Gomez-Gonzalez E, Madrazo A, Vera-Valencia M, Rodrigo L, Perez-Alvarez R, et al. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology (Baltimore, Md). 2008;47:810–6.

    Article  Google Scholar 

  57. Taura T, Nakamura K, Takashima S, Kaminou T, Yamada R, Shuto T, et al. Heterogeneity of hepatic parenchymal enhancement on computed tomography during arterial portography: quantitative analysis of correlation with severity of hepatic fibrosis. Hepatol Res: Off J Japan Soc Hepatol. 2001;20:182–92.

    Article  Google Scholar 

  58. Nakaura T, Nakamura S, Maruyama N, Funama Y, Awai K, Harada K, et al. Low contrast agent and radiation dose protocol for hepatic dynamic CT of thin adults at 256-detector row CT: effect of low tube voltage and hybrid iterative reconstruction algorithm on image quality. Radiology. 2012;264:445–54.

    Article  PubMed  Google Scholar 

  59. Hashimoto K, Murakami T, Dono K, Hori M, Kim T, Kudo M, et al. Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging. Oncol Rep. 2006;16:677–83.

    PubMed  Google Scholar 

  60. Ronot M, Asselah T, Paradis V, Michoux N, Dorvillius M, Baron G, et al. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology. 2010;256:135–42.

    Article  PubMed  Google Scholar 

  61. Lv P, Lin X, Gao J, Chen K. Spectral CT: preliminary studies in the liver cirrhosis. Korean J Radiol: Off J Korean Radiol Soc. 2012;13:434–42.

    Article  Google Scholar 

  62. Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, terBeek LC, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed. 2006;19:173–9.

    Article  PubMed  Google Scholar 

  63. Macarini L, Marini S, Milillo P, Vinci R, Ettorre GC. Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions. La Radiologiamedica. 2006;111:1087–102.

    CAS  Google Scholar 

  64. Lewin M, Poujol-Robert A, Boelle PY, Wendum D, Lasnier E, Viallon M, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md). 2007;46:658–65.

    Article  CAS  Google Scholar 

  65. Hagiwara M, Rusinek H, Lee VS, Losada M, Bannan MA, Krinsky GA, et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology. 2008;246:926–34.

    Article  PubMed  Google Scholar 

  66. Van Beers B. Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis. Bulletin et memoires de l’Academieroyale de medecine de Belgique. 2009;164:44–50; discussion 51–42.

    Google Scholar 

  67. Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61:409–15.

    Article  PubMed  Google Scholar 

  68. Noren B, Dahlqvist O, Lundberg P, Almer S, Kechagias S, Ekstedt M, et al. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur J Radiol. 2008;66:313–20.

    Article  PubMed  Google Scholar 

  69. Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007;245:458–66.

    Article  PubMed  Google Scholar 

  70. Rouviere O, Yin M, Dresner MA, Rossman PJ, Burgart LJ, Fidler JL, et al. MR elastography of the liver: preliminary results. Radiology. 2006;240:440–8.

    Article  PubMed  Google Scholar 

  71. Yoon JH, Lee JM, Woo HS, Yu MH, Joo I, Lee ES, et al. Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol: Off J Korean Radiol Soc. 2013;14:202–12.

    Article  Google Scholar 

  72. Polasek M, Fuchs BC, Uppal R, Schuhle DT, Alford JK, Loving GS, et al. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol. 2012;57:549–55.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Chow AM, Tan M, Gao DS, Fan SJ, Cheung JS, Qiao Z, et al. Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model. Invest Radiol. 2013;48:46–54.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Liver Surgery, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China

    Guangqin Xiao MD & Lunan Yan MD, PhD

Authors
  1. Guangqin Xiao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lunan Yan MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lunan Yan MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Surgery, West China Hospital, Chengdu, China

    Lunan Yan

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Xiao, G., Yan, L. (2016). Liver Fibrosis and Its Assessment. In: Yan, L. (eds) Operative Techniques in Liver Resection. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7411-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7411-6_5

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7409-3

  • Online ISBN: 978-94-017-7411-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation